





































Percutaneous cholecystostomy – An option in
selected patients with acute cholecystitis
Jon Arne Søreide, MD, PhD, FACS, FISSa,b,
∗
, Anja Fjetland, MDa, Kari F. Desserud, MDa,
Ole Jakob Greve, MDc, Lars Fjetland, MD, PhDc
Abstract
While urgent percutaneous cholecystostomy (PC) was introduced as an alternative to acute surgical treatment for acute cholecystitis
(AC), the current place of PC in the treatment algorithm for AC is challenged. We evaluate demographics and outcomes of PC in
routine clinical practice in a population-based cohort.
Retrospective evaluation of consecutive patients treated with PC for AC between 2000 and 2015. The severity of cholecystitis was
graded according to the 2013 Tokyo Guidelines.
One hundred forty-nine patients were included (82; 55% males) (median age of 72.5 years; range, 21–92). The Tokyo Guidelines
criteria of 2013 (TG13) severity grade distribution was 4%, 61.7%, and 34.2% for grades I, II, and III, respectively. No difference was
observed between males and females with regard to age, American Society of Anesthesiologists (ASA) score, comorbidities, or
previous history of cholecystitis. PCwas successfully performed in all but 1 patient, and complications were few andminor. Less than
half (48.3%) of all patients subsequently received definitive surgical treatment, mostly (83.3%) laparoscopy. No or minor
complications were encountered in 58 (80.6%) patients. Operated patients were significantly younger (P=<.001) and had lower ASA
scores (P= .005), less comorbidities (P< .001), and had more seldomly a severe grade 3 cholecystitis (P< .001) than non-operated
patients.
PC is useful in selected patients with AC. However, since only a half of the patients eventually received definitive surgical treatment,
a better routine decision-making based on proper criteria may enable an improved allocation of the individual patient for tailored
treatment according to the disease severity, the patient’s comorbidity burden, and also to the treatment options available at the
institution to prevent overutilization of a non-definitive treatment approach. Comprehension of this responsibility should be
acknowledged by hospitals with an emergency surgical service, although the clinical decision-making remains a challenge of the
responsible surgeon on call.
Abbreviations: AAC = acute acalculous cholecystitis, AC = acute cholecystitis, ACC = acute calculous cholecystitis, ASA =
American Society of Anesthesiology, CCI =Charlson comorbidity index, CRP=C-reactive protein, CT= computer tomography, IQR
= interquartile range, MT=magnetic tomography, PC= percutaneous cholecystostomy, RCT= randomized-controlled trial, TG13=
Tokyo Guidelines criteria of 2013, TG18 = Tokyo Guidelines criteria of 2018, US = ultrasound.
Keywords: acute cholecystitis, emergency surgery, laparoscopic cholecystectomy, percutaneous cholecystostomy, severity
criteria
1. Introduction
Acute cholecystitis (AC) is a common cause of acute hospitaliza-
tion.[1,2] The mean length of stay for AC decreased by 17% (i.e.,
from 4.7 to 3.9 days; P< .05) between 1997 and 2012 in the USA,
and the mean hospital charges increased by 195.4% during the
same time period.[2] Treatment traditions vary, as shown by the
difference in emergency cholecystectomy rates in the USA
(52.7%) compared to England (15.7%), with a laparoscopic
approach performed in 82.8% of patients in the USA and 37.9%
of patients in England.[3]
Controversies exist regarding the optimal treatment of AC, and
a number of aspects, including the approach (i.e., conservative
versus surgery), timing of surgery (acute versus delayed), type
of intervention (i.e., cholecystectomy versus partial gallbladder
resection or percutaneous cholecystostomy (PC)) have been
discussed.[1,4–10]Moreover, the severity of the gallbladder disease
as well as the patients’ clinical condition and comorbidities
should be considered to accomplish optimal individual decision-
making.[4,5,10,11]
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Since the introduction of ultrasound (US)-guided PC in
1983,[12] this modality has been considered a valuable treatment
alternative in the acute situation. This approach was reported as
safe and efficient,[13–17] especially in frail or high-risk patients
with severe cholecystitis.[4,11,18] However, the true place of PC in
the treatment algorithm for AC is still debated.[18–21]
This study was performed to evaluate patients’ clinical
patterns, technical success rates, and outcomes after treatment
with PC in a cohort of consecutive unselected patients with AC.
2. Methods
Stavanger University Hospital serves as the only hospital for an
urban and rural catchment area comprising a population of
around 380,000 people.
Due to our treatment traditions patients with AC were mostly
treated conservatively (i.e., typically with antibiotics). In elderly
and frail patients with significant comorbidities and a suggested
diagnosis of severe AC, PC was considered early in the course of
disease, as decided by the responsible surgeon. Moreover, PC
would be contemplated when a detrimental clinical course of
disease was encountered in spite of optimal conservative
treatment.[22]
2.1. Patients
The patients were identified based on information from the
diagnosis and procedure codes from the electronic hospital
records administrative systems.
AC was diagnosed based on clinical symptoms and signs (right
upper quadrant tenderness and a positive Murphy sign),
supported by laboratory data (elevated C-reactive protein
(CRP) levels and leukocytosis), and confirmed by imaging,
mostly by US but sometimes by computed tomography (CT).
Patients who underwent PC for reasons other than an ACwere
excluded from this study.
2.2. Diagnosis and classification of AC
Acute calculous cholecystitis (ACC) was diagnosed based on
symptoms, clinical findings, and imaging as described by
others.[23] Acute acalculous cholecystitis (AAC) is characterized
by severe gallbladder inflammation without cystic duct obstruc-
tion due to gallstones.[24]
The cholecystitis severity grading (grade 1–3) for this studywas
performed retrospectively according to the Tokyo Guidelines
criteria of 2013 (TG13).[25,26]
2.3. PC
A radiologist trained in US-guided interventions performed
the PC under conscious sedation and local anesthetics. The
gallbladder was directly punctured under sonographic guidance,
preferably through a small brim of liver.[27,28] A positive clinical
response was suggested when a resolution of clinical symptoms
and signs was encountered, with a decrease or disappearance in
pain, fever, and leukocytosis or CRP levels, along with the
absence of adverse events related to PC or catheter removal.[22]
A follow-up fluoroscopic biliary study with contrast was
mostly performed 3 to 5 days after the PC to evaluate if contrast
could pass the cystic duct and to assess if contrast reached the
duodenum. The drain was clamped and removed the next day if
free contrast passage was confirmed and clinical condition was
improving. The catheter was left in place if no contrast passage
was visualized. Patients in good general clinical condition were
discharged with the drain in place, and a secondary cholangiog-
raphy was performed after another 2 to 3 weeks. In most cases,
the catheter was removed at this time.
At a surgical out-patient clinic consultation 4 to 6 weeks after
PC, indications for an elective cholecystectomy was discussed
with the patient, and scheduled for at least 2 to 3 months after the
index admission
2.4. Complications
Postoperative complications (i.e., related to the delayed chole-
cystectomy) were categorized according to the Clavien–Dindo
classification system.[29,30] Class 0 to II include no or minor
complications, and class ≥III include major complications.
2.5. Ethical approval and consent to participate
All procedures performed were in accordance with the ethical
standards of the institutional and/or national research committee
and with the 1964 Helsinki declaration and its later amendments
or comparable ethical standards.
The study was approved by the Regional Committee for
Medical and Health Research Ethics, University of Bergen,
Bergen, Norway (ref. no. 2015/1496/REK-Vest). This approval
includes the consent for publication.
2.6. Statistics
IBM Statistics SPSS forMac v.25 was used for statistical analysis.
Results are reported as the median (range) for continuous
variables and proportions (percentages) for categorical variables.
A non-normal distribution was suggested for the continuous
variables. The Mann–Whitney U test was used to analyze
differences between continuous variables, and the chi-square test
was used to compare categorical variables. A P-value <.050 was
regarded as statistically significant.
The results are reported according to the STROBE criteria for
observational studies.[31]
3. Results
Between 2000 and 2015, a total of 149 patients (82; 55% males;
median age of 72.5 (range, 21–92) years) with AC were treated
with PC. Demographics and clinical characteristics are displayed
in Table 1. No significant differences between males and females
were observed with regard to age, ASA score, comorbidity/
Charlson comorbidity index (CCI), or previously reported
history of bile colic or cholecystitis. While the AC severity
grades (TG13 criteria[25]) were similarly distributed between
sexes, acalculous cholecystitis was significantly (P= .006) more
common in males (19.5%) than in females (4.5%) (Table 1).
When younger patients (i.e., median <72.5 years of age) were
compared with older patients, no differences were found with
regard to sex distribution or history of previous biliary colic or
AC. In contrast, the ASA score distribution (P< .003), CCI
(P< .001), and TG13 severity grades (P= .004) differed signifi-
cantly between age groups (Fig. 1). Moreover, as shown in
Figure 2, the severity of AC at admission to the hospital differed
significantly (P< .005) according to the comorbidity category of
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the patients, with the highest proportion of patients with severe
cholecystitis (i.e., TG13 grade 3) found in patients with the
greatest comorbidity burden (i.e., CCI≥3).
Duration symptoms before admission to the hospital was
median 2 days. AC occurred as an in-hospital complication in 12
(8%) patients admitted for other medical conditions. Five of these
12 patients had acalculous cholecystitis, which was a significantly
higher proportion than that among patients (14/137; 10.2%)
diagnosed with acalculous cholecystitis at admission to the
hospital (P< .001).
Figure 1. Distribution of ASA class, Charlson comorbidity index (CCI), and severity of acute cholecystitis (TG13) in younger (i.e.,<median age of 72.5yr) and older
(≥72.5yr) patients.
Table 1
Demographics and clinical characteristics of 149 patients accord-
ing to sex.
Variable Males 82; 55% Females 67; 45% P-value
Age, yr
Median (range) 69.5 (24.5–90.5) 74.5 (21.5–92.0) n.s.
∗
ASA score
I 13 (14.6) 16 (23.9) .363†
II 40 (48.8) 31 (40.3)
II 26 (31.7) 18 (26.9)
IV 2 (2.4) 0
Unknown 1 (1.2) 2 (3.0)
Comorbidity
Yes 68 (82.9) 50 (74.6) .284†
No 14 (17.1) 15 (25.4)
Charlson comorbidity index (CCI)
Median (range) 2 (0–11) 1 (0–8) n.s.
∗
CCI=0 22 (26.8) 21 (31.3) .409†
CCI=1 16 (19.5) 17 (25.4)
CCI=2 11 (13.4) 9 (13.4)
CCI≥3 32 (39.0) 17 (25.4)
Unknown 1 (1.2) 3 (4.5)
CCI 0–1 38 (46.3) 38 (56.7) .207†
CCI≥2 44 (53.7) 29 (43.3)
Previous bile colic
Yes 36 (43.9) 22 (32.8) .173†
No 44 (53.7) 43 (64.2)
Unknown 2 (2.4) 2 (3.0)
Previous cholecystitis
Yes 17 (20.7) 14 (20.9) .936†
No 64 (78.1) 51 (76.1)
Unknown 1 (1.2) 3 (4.5)
Type of cholecystitis
Calculous 66 (80.5) 64 (95.5) .006†
Acalculous 16 (19.5) 3 (4.5)
Tokyo classification of acute cholecystitis
Grade 1 (mild) 3 (3.7) 2 (3.0) .493†
Grade 2 (moderate) 44 (53.7) 43 (64.2)
Grade3 (severe) 31 (37.8) 20 (29.8)
Unknown 4 (4.9) 2 (3.0)
n.s.=non significant; % in ( ).
∗
Mann–Whitney U test for non-parametric continuous variables.
† Chi-square test for categorical variables.
Figure 2. Distribution of severity grade (TG13) by CCI groups.
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US, either alone or in combination with other biliary imaging
modalities (i.e., mostly CT), was employed in more than 70% of
the patients; 25% underwent CT alone, and very few had
magnetic tomography (MT) alone or in combination with US.
Half of the PC procedures (51%) were completed during
normal working hours. Insertion of the drain was successful in all
but 1 patient due to lack of cooperation. Typically, the
transhepatic route was used, and this approach was confirmed
in 75 (50.2%) of the patients. Direct puncture of the gallbladder
was performed in 18 (12.1%) of the patients. Reliable
information to confirm the exact catheter route was not
available in the remaining patients.
Except for transitory and moderate pain in some patients, no
severe adverse advents after PC were noted. Minor bleeding was
observed in 2 patients, and 1 patient suffered from transient pain-
related dyspnea for a few hours.
A pericholecystic abscess was found in 21 (14%) of the
patients. A positive bacterial culture, either from blood or bile
samples, was obtained in 70 (47%) of the patients. Escherichia
coliwas the most frequently encountered bacteria, either alone or
in combination with other bacteria.
Scheduled follow-up cholangiography was performed at a
median of 5 days after insertion of the drain. Free passage of
contrast to the duodenum was confirmed in 73 (49%) patients.
Of note, 33 patients (22%) had drains removed unintentionally
in the ward, but only 13 of these patients (i.e., less than one-third)
required repeated PC. In the remaining 20 patients, reinterven-
tion was not recommended due to their improving clinical
conditions. Thus, in 27 patients (18%), postprocedural follow-up
cholangiography was not possible, mostly (20/27=74%) due to
unintentional removal of the drain without replacement.
The 30-day mortality rate after admission was 5.4% (8
patients) including 4 related to biliary sepsis and 1 to biliary
severe pancreatitis. The remaining 3 frail patients died from other
medical causes (i.e., cardiovascular or pulmonary incidents). A
cumulative 90-day mortality rate of 7.4% (11/149) was
observed. No deaths were related to the PC procedure itself.
Definitive surgical treatment was eventually performed in 72
patients (48.3%), including 35 (48.6%) females. As seen in
Table 2, the operated patients were younger (P< .001), had a
lower ASA score (P= .005), and a lower CCI (P< .001).
Moreover, the cholecystitis severity grade was lower in patients
who underwent subsequent surgery (P< .001).
Surgical treatment was employed in 7 patients (9.9%), and 32
patients (50%), within 30 days and 3 months, respectively. And
95% of the surgically treated patients had been operated within a
year from the index admission. However, around one-third (24/
72) of the operated patients had a new AC episode with
readmission to the hospital before definitive surgery could be
completed.
A laparoscopic approach was used in 60 patients (60/72=
83.3%), including 57 cholecystectomies and 3 partial gallbladder
resections. Conversion to open cholecystectomy was necessary in
3 patients (4.3%) due to perioperative challenges related to
extensive inflammation. No or minor postoperative complica-
tions (i.e., Clavien–Dindo class I–II) were recorded in 54 (80.6%)
of the operated patients. No bile duct injury was recorded.
During a median follow-up of 56 months (interquartile range
(IQR), 26–100months), 62 patients (42%) eventually died, and 3
were lost to follow-up due to emigration (Fig. 3). However,
during the first year after the index admission, 18.2% (14/77) of
the non-operated patients died of causes unrelated to gallbladder
disease compared to 2.7% (2/72) of the surgically treated patients
(P= .006). Thus, PCwas the final treatment in 77 patients (52%),
of whom 15 patients (19.5%) were eventually readmitted with a
new episode of AC. Altogether, 39 (26.2%) patients (i.e., 24
(33.3%) of the operated and 15 (19.5%) of the non-operated
patients) had at least 1 readmittance to the hospital for
cholecystitis-related complaints or symptoms. The cumulative
death rates for the non-operated patients were 18.2%, 31.2%,
and 37.7%, at 1, 2, and 3 years after the index admission,
respectively.
Table 2
Clinical characteristics of operated and non-operated patients.
Not-operated, N=77 Operated, N=72 P-value
Age (median, range) (yrs) 77 (26–91) 61 (21–91) <.001
Sex
Females 32 (41.6%) 36 (50.0%) .301
Males 45 (58.4%) 36 (50.0%)
ASA class
I 10 (13.0%) 20 (27.8%) .005
II 34 (44.2%) 39 (54.2%)
III 31 (40.3%) 13 (18.1%)
IV 2 (2.6%) 0
CCI category
0 11 (15.3%) 31 (44.9%) <.001
1 15 (20.8%) 18 (26.1%)
2 13 (18.1%) 7 (10.1%)
≥3 33 (45.8%) 13 (18.8%)
TG13 class
Grade 1 mild 2 (2.6%) 4 (5.6%) <.001
Grade 2 moderate 36 (46.8%) 56 (77.8%)
Grade 3 severe 39 (50.6%) 12 (16.7%)
Figure 3. Survival of the patients (Kaplan–Meier plot) according to whether
definitive surgical treatment was completed or not.
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4. Discussion
The majority of patients responded properly to the initial
treatment with PC. No procedure-related deaths were observed,
although 3 patients died during the index admission because of
severe infection. Thus, as also reported by others,[11,32–35] PC is
regarded as a safe procedure of selected patients with AC.
Catheter dislodgement was observed in 22% of our patients.
Of note, less than half (39%) of these patients needed a new
percutaneous drain. While complications were rare in this study,
a wide range of uncommon complications including hemorrhage,
vagal reactions, bile peritonitis, sepsis, pneumothorax, bowel
perforation, or secondary infection have been reported.[27,28]
Subsequent cholecystectomy, either early or delayed, is
considered an important part of the definitive treatment of
patients with AC.[1,5,10] While recent studies[9,36,37] have
provided convincing support for early surgical treatment in
patients with AC, surgery is often postponed in multimorbid or
frail patients in particular, either due to different practices,[3]
opinions,[38] or experience with subgroups of patients.[22,39]
Thus, more than 50%, as recently summarized by Stanek et al,[40]
never undergo definitive surgery, which is in line with 48.3%
surgically treated patients observed in this study. Moreover, in a
large population-based study by Lu et al,[21] only 36.4% of the
11,184 patients who were treated with PC eventually underwent
subsequent cholecystectomy, which parallels 31.4% as reported
recently from Canada.[41]
Among the 72 (48.3%) patients who underwent surgery in this
study, about one-third (24 patients) were readmitted with a new
episode of AC before surgery could be completed. Moreover,
within a year from the index admittance, 2.7% (2/72) of the
surgically treated patients had died in contrast to 18.2% (14/77)
of the non-operated patients (P< .01). Notably, patients who
died were older and had significant comorbidities. Thus, this
survival difference is likely explained by patient selection.
In a recent nationwide randomized-controlled trial (RCT) from
the Netherlands (CHOCOLATE-study) on high-risk patients
(i.e., APACHE II≥7) with AC, laparoscopic cholecystectomy
was compared with percutaneous catheter drainage.[42] The
authors concluded that both from a clinical and economical point
of view, laparoscopic cholecystectomy should be the preferred
strategy compared with PC.[42] However, as with all RCTs, a
number of exclusion criteria distorted the study population, and
direct comparison with unselected consecutive routine patients
(i.e., our study population) is challenging.
We used the previous TG13 for our retrospective classification
of disease severity. The diagnostic criteria and classification of
AC remained the same in the most recent 2018 version of these
guidelines.[43,44] Of note, indications for PC for patients with AC
were not based on strict predefined criteria in our routine
practice. By reviewing our unselected patient cohort, it seems
obvious that rather than using criteria for the severity of AC, the
indications for PC were mainly guided by the surgeon’s
perception of a compromised patient with an obvious comorbid-
ity, thus regarded at an increased risk of acute surgery. This
approach is also in accordance with others, as recently reviewed
by Dimou and Riall.[45]
The duration of gallbladder drainage varies remarkably
between 2 and 193 days in different studies.[28,46] Our own
routine aims at an early catheter cholangiography (i.e., after 3–5
days), to prepare for an early removal of the drain when the
clinical conditions allowed. We achieved this goal in approxi-
mately half of the patients. Some authors claim that the drain
should routinely remain for at least 2 to 4 weeks to ascertain
proper drainage.[28,45,46] As summarized in a recent systematic
review, at the moment there is no evidence regarding whether the
duration of the PC tube may affect outcomes.[47]
As shown in Figure 1, patients <72.5 years (i.e., the median
age) had less compromised physical condition (i.e., lower ASA
score) and comorbidities (i.e., lower CCI) than older patients, and
often mild or moderate AC. Indications for PC are outlined in a
recent international consensus report[4] and described in the
TG13[26] and the most recent Tokyo Guidelines criteria of 2018
(TG18).[43] Based on the retrospective review of the patients, and
evaluation of the severity of the AC, we now think that PC may
have been overutilized in some patients in this study.
A strength of this study is the population-based unselected
study population. Referral bias is unlikely. The retrospective
classification of the severity of cholecystitis according to the TG
criteria was performed by experienced clinicians and radiologists
who reviewed available clinical information and recorded
imaging files. A complete follow-up was possible by collecting
appropriate information from the hospital records, which are
linked to Statistics Norway (www.ssb.no), to provide the date of
death in deceased patients.
The retrospective design of this study is an obvious limitation.
In spite of this, data completeness was good, which allows for a
reliable evaluation of the routine clinical use of PC in patients
suggested to have severe AC during that time period.
5. Conclusions
Although feasible and safe, and useful in a select group of
patients, PC should not be overutilized when alternative and
more definitive surgical treatment approaches are indicated and
possible. Proper clinical decision-making should be based on
scientific evidence. In routine practice, decision-making should
rest on reasonable criteria that take into consideration both the
individual patient’s condition and comorbidity burden as well as
the disease severity. All hospitals with an emergency surgical
service that has the clinical treatment responsibility of patients
with acute cholecystitis should have a masterplan for the
management of these often frail and elderly patients. Mutual
collaboration with other specialists, including radiologists,
intensivists and others, is recommended. However, the clinical
decision-making of the individual patient with acute cholecystitis
remains a challenge primarily for the responsible surgeon
involved.
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